Hayette S - Search Results

1

Evidence that resistance to nilotinib may be due to BCR-ABL, Pgp, or Src kinase overexpression.

Mahon FX, Hayette S, Lagarde V, Belloc F, Turcq B, Nicolini F, Belanger C, Manley PW, Leroy C, Etienne G, Roche S, Pasquet JM. Mahon FX, et al. Among authors: hayette s. Cancer Res. 2008 Dec 1;68(23):9809-16. doi: 10.1158/0008-5472.CAN-08-1008. Cancer Res. 2008. PMID: 19047160

2

Real life evaluation of AlphaMissense predictions in hematological malignancies.

Chabane K, Charlot C, Gugenheim D, Simonet T, Armisen D, Viailly PJ, Codet de Boisse G, Huet S, Hayette S, Alcazer V, Sujobert P. Chabane K, et al. Among authors: hayette s. Leukemia. 2024 Feb;38(2):420-423. doi: 10.1038/s41375-023-02116-3. Epub 2023 Dec 22. Leukemia. 2024. PMID: 38135759

3

Next-CLL, a New Next-Generation Sequencing-Based Method for Assessment of IGHV Gene Mutational Status in Chronic Lymphoid Leukemia.

Bourbon E, Chabane K, Mosnier I, Bouvard A, Thonier F, Ferrant E, Michallet AS, Poulain S, Hayette S, Sujobert P, Huet S. Bourbon E, et al. Among authors: hayette s. J Mol Diagn. 2023 May;25(5):274-283. doi: 10.1016/j.jmoldx.2023.01.009. Epub 2023 Feb 10. J Mol Diagn. 2023. PMID: 36773701 Free article.

4

Clinical outcome of therapy-related acute myeloid leukemia patients. Real-life experience in a University Hospital and a Cancer Center in France.

Belhabri A, Heiblig M, Morisset S, Vila L, Santana C, Nicolas-Virelizier E, Hayette S, Tigaud I, Plesa A, Labussiere-Wallet H, Sobh M, Michallet AS, Marie B, Nicolini FE, Guillermin Y, Gaëlle F, Lebras L, Rey P, Jauffret-Bertholon L, Laude MC, Sandrine L, Michallet M. Belhabri A, et al. Among authors: hayette s. Cancer Med. 2023 Aug;12(16):16929-16944. doi: 10.1002/cam4.6322. Epub 2023 Aug 7. Cancer Med. 2023. PMID: 37548369 Free PMC article.

5

Identification of a rare e6a2 BCR-ABL fusion gene during the disease progression of chronic myelomonocytic leukemia: a case report.

Hayette S, Tigaud I, Thomas X, French M, Perrin MC, Nicolini F, Michallet M, Magaud JP. Hayette S, et al. Leukemia. 2004 Oct;18(10):1735-6. doi: 10.1038/sj.leu.2403476. Leukemia. 2004. PMID: 15356652 No abstract available.

6

Assessment and follow-up of the proportion of T315I mutant BCR-ABL transcripts can guide appropriate therapeutic decision making in CML patients.

Hayette S, Michallet M, Baille ML, Magaud JP, Nicolini FE. Hayette S, et al. Leuk Res. 2005 Sep;29(9):1073-7. doi: 10.1016/j.leukres.2005.02.006. Epub 2005 Mar 23. Leuk Res. 2005. PMID: 16038734

7

Identification of a rare e8a2 BCR-ABL fusion gene in three novel chronic myeloid leukemia patients treated with imatinib.

Cayuela JM, Rousselot P, Nicolini F, Espinouse D, Ollagnier C, Bui-Thi MH, Chabane K, Raffoux E, Callet-Bauchu E, Tigaud I, Magaud JP, Hayette S. Cayuela JM, et al. Among authors: hayette s. Leukemia. 2005 Dec;19(12):2334-6. doi: 10.1038/sj.leu.2403986. Leukemia. 2005. PMID: 16224485 No abstract available.

8

Mobilization of autologous hematopoietic progenitors and subsequent transplantation is a safe and feasible procedure in chronic phase chronic myelogenous leukemia patients with cytogenetic resistance to imatinib.

Prebet T, Tigaud I, Hayette S, Clapisson G, Philip I, Michallet M, Nicolini FE. Prebet T, et al. Among authors: hayette s. Haematologica. 2005 Nov;90 Suppl:ECR36. Haematologica. 2005. PMID: 16266927 No abstract available.

9

The role of the K247R substitution in the ABL tyrosine kinase domain in sensitivity to imatinib.

Nicolini FE, Chabane K, Cayuela JM, Rousselot P, Thomas X, Hayette S. Nicolini FE, et al. Among authors: hayette s. Haematologica. 2006 Jan;91(1):137-8. Haematologica. 2006. PMID: 16434384

10

Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(phi)-LMC GROUP).

Nicolini FE, Corm S, Lê QH, Sorel N, Hayette S, Bories D, Leguay T, Roy L, Giraudier S, Tulliez M, Facon T, Mahon FX, Cayuela JM, Rousselot P, Michallet M, Preudhomme C, Guilhot F, Roche-Lestienne C. Nicolini FE, et al. Among authors: hayette s. Leukemia. 2006 Jun;20(6):1061-6. doi: 10.1038/sj.leu.2404236. Leukemia. 2006. PMID: 16642048

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters